Results 151 to 160 of about 40,504 (198)

Vitamin D and the metabolic-associated steatotic liver disease-type 2 diabetes axis: a scoping-narrative review of global evidence and emerging perspectives for Sub-Saharan Africa. [PDF]

Front Epidemiol
Basil B.
europepmc   +1 more source

Alternative Administration of Antiretroviral Therapy in People with HIV Unable to Swallow: A Scoping Review. [PDF]

HIV AIDS (Auckl)
Abdessamad H, Baroody C, Pogorzelski K, Jamaleddine W, Kitonga MS, Omar H, Amankrah SA, Allen-Brown K, Dandachi D.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Efavirenz

Journal of the Association of Nurses in AIDS Care, 2000
Item does not contain ...
Aarnoutse, R.E., Burger, D.M., Koopmans †, P.P.   +2 more
openaire   +4 more sources

Efavirenz

Drugs, 1998
Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) which shows good inhibitory activity against HIV-1. Reduced susceptibility to efavirenz has been reported with HIV-1 variants containing single and multiple mutations to the reverse transcriptase enzyme.
J C, Adkins, S, Noble
openaire   +2 more sources

Efavirenz

Expert Opinion on Pharmacotherapy, 2007
Treatment of HIV infection is typically carried out using a combination of at least three drugs. Efavirenz is a non-nucleoside reverse transcriptase inhibitor that acts by non-competitive inhibition of the viral enzyme. Efavirenz-based regimens have performed favorably compared with protease inhibitor-based therapies either in naive patients or as ...
openaire   +3 more sources

Efavirenz

Drugs, 2012
exaly   +2 more sources